Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synergizing the potential of bacterial genomics and metabolomics to find novel antibiotics
Fabian Panter, Chantal D. Bader, Rolf Müller
Chemical Science (2021) Vol. 12, Iss. 17, pp. 5994-6010
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Marine drugs: Biology, pipelines, current and future prospects for production
Nicolas Papon, Brent R. Copp, Vincent Courdavault
Biotechnology Advances (2021) Vol. 54, pp. 107871-107871
Open Access | Times Cited: 61
Constructing a Myxobacterial Natural Product Database to Facilitate NMR-Based Metabolomics Bioprospecting of Myxobacteria
Degao Wang, Chaoyi Wang, Jia-Qi Hu, et al.
Analytical Chemistry (2023) Vol. 95, Iss. 12, pp. 5256-5266
Closed Access | Times Cited: 18
Recent advances in discovery and biosynthesis of natural products from myxobacteria: an overview from 2017 to 2023
Chaoyi Wang, Jia-Qi Hu, Degao Wang, et al.
Natural Product Reports (2024) Vol. 41, Iss. 6, pp. 905-934
Closed Access | Times Cited: 5
Genome-Guided Discovery of the First Myxobacterial Biarylitide Myxarylin Reveals Distinct C–N Biaryl Crosslinking in RiPP Biosynthesis
Joachim J. Hug, Nicolas Frank, Christine Walt, et al.
Molecules (2021) Vol. 26, Iss. 24, pp. 7483-7483
Open Access | Times Cited: 35
Metabolomics- and systems-biology-guided discovery of metabolite lead compounds and druggable targets
Amelia Palermo
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103460-103460
Open Access | Times Cited: 22
Drug Discovery from Natural Sources
David Newman
Current Pharmacology Reports (2023) Vol. 9, Iss. 2, pp. 67-89
Closed Access | Times Cited: 11
Structure Elucidation of Secondary Metabolites: Current Frontiers and Lingering Pitfalls
Mikaela DiBello, Alan R. Healy, Herman Nikolayevskiy, et al.
Accounts of Chemical Research (2023) Vol. 56, Iss. 12, pp. 1656-1668
Open Access | Times Cited: 11
Accessing hidden microbial biosynthetic potential from underexplored sources for novel drug discovery
Lei Li
Biotechnology Advances (2023) Vol. 66, pp. 108176-108176
Closed Access | Times Cited: 10
Challenging old microbiological treasures for natural compound biosynthesis capacity
Imen Nouioui, Alina Zimmermann, Oliver Hennrich, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 2
Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products
Yushan Xu, Xinhua Du, Xionghui Yu, et al.
Marine Drugs (2022) Vol. 20, Iss. 6, pp. 341-341
Open Access | Times Cited: 13
Metabolomics of natural samples: A tutorial review on the latest technologies
Ali Baba Eshawu, Vihang Vivek Ghalsasi
Journal of Separation Science (2023) Vol. 47, Iss. 1
Closed Access | Times Cited: 7
Advances in Biosynthesis of Natural Products from Marine Microorganisms
Quan Zhou, Kinya Hotta, Yaming Deng, et al.
Microorganisms (2021) Vol. 9, Iss. 12, pp. 2551-2551
Open Access | Times Cited: 19
Next-generation synthetic biology approaches for the accelerated discovery of microbial natural products
Lei Li
Engineering Microbiology (2022) Vol. 3, Iss. 1, pp. 100060-100060
Open Access | Times Cited: 12
Single cell mutant selection for metabolic engineering of actinomycetes
Amir Akhgari, Bikash Baral, Arina Koroleva, et al.
Metabolic Engineering (2022) Vol. 73, pp. 124-133
Open Access | Times Cited: 10
Natural products in antibiotic development: is the success story over?
Freddy A. Bernal, Peter Hammann, Florian Kloß
Current Opinion in Biotechnology (2022) Vol. 78, pp. 102783-102783
Closed Access | Times Cited: 10
Identification of the lipodepsipeptide selethramide encoded in a giant nonribosomal peptide synthetase from aBurkholderiabacterium
Sean B. Romanowski, Sang Hyeon Lee, Sylvia Kunakom, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 42
Open Access | Times Cited: 5
The Natural Products Discovery Center: Release of the First 8490 Sequenced Strains for Exploring Actinobacteria Biosynthetic Diversity
Edward Kalkreuter, Satria A. Kautsar, Dong Yang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5
Autologous DNA mobilization and multiplication expedite natural products discovery from bacteria
Feng Xie, Haowen Zhao, J. Liu, et al.
Science (2024) Vol. 386, Iss. 6727
Closed Access | Times Cited: 1
Bursts in biosynthetic gene cluster transcription are accompanied by surges of natural compound production in the myxobacterium Sorangium sp.
Judith Boldt, Laima Lukoševičiūtė, Chengzhang Fu, et al.
Microbial Biotechnology (2023) Vol. 16, Iss. 5, pp. 1054-1068
Open Access | Times Cited: 4
Genome Mining and Metabolomics Unveil Pseudonochelin: A Siderophore Containing 5-Aminosalicylate from a Marine-Derived Pseudonocardia sp. Bacterium
Fan Zhang, René F. Ramos Alvarenga, Kurt Throckmorton, et al.
Organic Letters (2022) Vol. 24, Iss. 22, pp. 3998-4002
Open Access | Times Cited: 8
Interplay of emerging and established technologies drives innovation in natural product antibiotic discovery
Chantal D. Bader, Angela L Nichols, Dong Yang, et al.
Current Opinion in Microbiology (2023) Vol. 75, pp. 102359-102359
Closed Access | Times Cited: 3
Screening of Strains of the Medicinal Mushroom Fomitopsis officinalis (vill.) Bondartsev & Singer Promising for Biotechnological Use
Оksana Mykchaylova, Natalia Poyedinok, Valeria Shchetinin
Innovative Biosystems and Bioengineering (2023) Vol. 6, Iss. 3-4, pp. 110-118
Open Access | Times Cited: 2
Isolation of two new stereochemical variants of streptophenazine by cocultivation of Streptomyces NIIST-D31, Streptomyces NIIST-D47, and Streptomyces NIIST-D63 strains in 3C2 combinations
D. K. Induja, A. R. S. Jesmina, Manu M. Joseph, et al.
The Journal of Antibiotics (2023) Vol. 76, Iss. 10, pp. 567-578
Closed Access | Times Cited: 2
Metabolomics in drug discovery: Restoring antibiotic pipeline
Faiza Azhar, Mariam Busharat, Shah Rukh Arshad Chaudhary, et al.
Asian Pacific Journal of Tropical Biomedicine (2023) Vol. 13, Iss. 9, pp. 378-383
Open Access | Times Cited: 2
Generation of host-pathogen interaction data: an overview of recent technological advancements
Fatima Noor, Usman Ali Ashfaq, Hafiz Rameez Khalid, et al.
Elsevier eBooks (2024), pp. 53-79
Closed Access
Page 1 - Next Page

Scroll to top